PetVivo Meets Growing Demand for Spryng™ with Appointment of Veterinary Surgeon, Kirsty Husby, as Senior Technical Services Veterinarian Expert Capablites of Senior Vet-Tech to Help Drive Greater Adoption of Spryng as Breakthrough Treatment of Osteoarthritis for Companiaon Animals MINNEAPOLIS, MN, & Annapolis Junction, MD, US,...

PETVIVO HOLDINGS, INC. ANOUNCES LAUNCH OF NEW COMPANY AND PRODUCT WEBSITES MINNEAPOLIS, March 07, 2022 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (NASDAQ: PETV & PETVW) ("PetVivo") an emerging biomedical device company focused on the commercialization of innovative...

PetVivo Reports Second Quarter 2022 Financial Results - Updated Raised approximately 11.25 million in connection with Initial Public Offering Rebranded Kush™ as Spryng™ and commenced sales of Spryng™ Conference call begins at 4:00 p.m. Central time today EDINA,...

PetVivo Holdings Announces Closing of Public Offering and Nasdaq Listing MINNEAPOLIS, MN, Aug. 13, 2021 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (Nasdaq: PETV, PETVW) (“PetVivo” or the “Company”), an emerging biomedical device company focused on the licensing and...

PetVivo Holdings Announces Pricing of Public Offering and Nasdaq Listing MINNEAPOLIS, MN, Aug. 10, 2021 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (Nasdaq: PETV, PETVW) (“PetVivo” or the “Company”), an emerging biomedical device company focused on the licensing and...